Navigation Links
BioMed Realty Trust Reports First Quarter 2008 Financial Results
Date:4/30/2008

good progress in our development and redevelopment pipeline, and steady progress in our leasing program. We remain cautiously optimistic that the limited correlation between the currently volatile credit markets and the long-term demand for research in the life science industry will allow us to continue our stable growth through 2008 and beyond," commented Alan D. Gold, President and Chief Executive Officer of BioMed Realty Trust.

First Quarter 2008 Financial Results

Rental revenues for the quarter were $50.3 million, representing a 6.0% increase versus the first quarter of 2007. Same property net operating income increased 4.9% on a cash basis for the first quarter of 2008 compared to the first quarter of 2007.

Total revenues for the quarter were $67.4 million, compared to $68.8 million in the first quarter of 2007. Total revenues, net income and FFO for the first quarter of 2007 included the effect of a $4.8 million lease termination fee (or approximately $0.07 per diluted share) related to the company's Elliott Avenue property. Net income available to common stockholders for the quarter was $12.6 million, or $0.19 per diluted share, compared to $16.0 million, or $0.25 per diluted share, in the first quarter of 2007.

FFO during the quarter was to $31.3 million, compared to $34.2 million in the comparable period in 2007. FFO per diluted share was $0.46 for the first quarter of 2008 versus $0.50 in the first quarter of 2007.

FFO is a supplemental non-GAAP financial measure used in the real estate industry to measure and compare the operating performance of real estate companies. A complete reconciliation containing adjustments from GAAP net income available to common stockholders to FFO and a definition of FFO are included at the end of this release.

Financing Activity

On February 13, 2008, the company's joint venture with Prudential Real Estate Investors entered into a secured construction loan facility with Wachovia
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. BioMed Realty Trust to Report 2008 First Quarter Results
2. The BBVA Foundation awards its 2007 Biomedicine Chairs
3. HHS Names First Director of the Biomedical Advanced Research Development Authority
4. BioMed Realty Trust Announces 90,000 Square Foot Lease at Pacific Research Center
5. DeBakey Awards to Recognize Excellence in Biomedical Research Journalism
6. LA BioMed to honor 3 of its legendary
7. Response Biomedical Corporation Reports 2007 Financial Results
8. Response Biomedical Corporation Moves to New Facility
9. Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
10. LA BioMed researcher says unexpected increase in cancer risk found
11. LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...LE, N.Y., Nov. 21 A prestigious gr...roviders will gather in Williamsburg, VA on March ...ctical, clinical information on cutting-edge thera... innovative research advances that impact patient ...d registration information is available at www.bi...
(Date:11/21/2008)...RK Tobacco use is more prevalent and smoking ce...eficit Hyperactivity Disorder (A.D.H.D.) In a stu...vity symptoms, those who exhibited elevated hypera...on, showed lower quit rates after 8 weeks than tho...t the A.D.H.D. symptoms. The study, now available...
(Date:11/21/2008)...S, Nov. 21 Three Minnesotans who s...during a special on-ice presentation at,the Minne...enter. The winners,were participants in The QuitC...earWay Minnesota(SM) and QUITPLAN(R) Services. , ...n cash, while two runners-up,will get $1,000 gift...
(Date:11/21/2008)...S, Nov. 21 In a recent announcemen... the Sales and Use Tax to include,"luxury" items ...e an increase,in animal shelter overpopulation. ...ning forces and urging all pet owners to take acti... to stop this tax. , "Our companion animals...
Breaking Medicine News(10 mins):Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...s have called on the medical profession to push Go...tween Indigenous and non-Indigenous Australians . ...ia, Dr Mark Wenitong, President of the Australian ...his co-authors from the National Aboriginal Commun...
... to reduce the risk of diabetes in the Indigenous ...byn McDermott, Pro-vice Chancellor of the Division...tralia, shows that while clinical care of adults w...ed, more Indigenous Australians are developing the...
...oxidant coenzyme Q10 appear to increase blood leve...s with Parkinsons disease , but does not improve ... Parkinsons disease is a neurodegenerative disorde...culty with walking or other movements. The biologi...
...lves in the mouth like a popular breath-freshener ...e to infants in impoverished areas. The innovativ...ins undergraduate biomedical engineering students....seven-student team fabricated a thin film that sho...
Other Medicine News:Health News:Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 3
(Date:11/19/2008)... Roche- , , MONTVALE, N.J., Nov. 19 /PRNews...asdaq: MEMY ) today announced that it has achiev...487/MEM 3454, its lead alpha-7 nicotinic receptor ...chizophrenia (CIAS). The Company has randomized 2...0 million payment from its partner Roche. Memory ...
(Date:11/18/2008)...re-USNewswire/ -- Forty-two leading U. S. scientis... forum to consider cutting-edge innovations that m...nomy from outbreaks of dangerous zoonotic diseases...g those innovations: , , , , A ...t detects highly contagious and dangerous zoonotic...
(Date:11/13/2008)...l Supplements Prior to Surgery, ARLINGTON HEIGHTS...ying,malnutrition before surgery in massive weight...icantly decrease surgical complications, accelerat...tient energy levels,according to a study in the D...y(R), the official medical journal of the American...
(Date:11/12/2008)...el, November 12 Surgeons,at the Un... that,patient-specific CTA data can be converted t...bionix US) with high face validity. The surgeons,"...operative flow,increased patient safety and effic...ve and fluoroscopy time and the amount of contrast...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Panacea Pharmaceuticals Announces the Availability of BC Detect 28SM 29 a Serum Based Diagnostic Test for Breast Cancer 1309 1Panacea Pharmaceuticals Announces the Availability of BC Detect 28SM 29 a Serum Based Diagnostic Test for Breast Cancer 1309 2Panacea Pharmaceuticals Announces the Availability of BC Detect 28SM 29 a Serum Based Diagnostic Test for Breast Cancer 1309 3Panacea Pharmaceuticals Announces the Availability of BC Detect 28SM 29 a Serum Based Diagnostic Test for Breast Cancer 1309 4Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 1Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 2Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 3Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 4Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 5Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 1304 6Mirixa Debuts RxFYI a Free Pharmacy Published Health eNewsletter Building Patient Loyalty and Generating Revenue 3893 1Mirixa Debuts RxFYI a Free Pharmacy Published Health eNewsletter Building Patient Loyalty and Generating Revenue 3893 2ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 1ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 2ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 3ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 4ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 5ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 6ImClone and Bristol Myers Squibb Announce Joint Agreement With Merck KGaA to Co Develop and Co Commercialize ERBITUX 28R 29 in Japan 3889 7
...SINESS WIRE)--Jun 5, 2007 - First-in-human results...mClone Systems,Incorporated (NASDAQ: IMCL) and tar... receptor), were presented at the annual,meeting o...cago.,The IGF-IR is expressed on the cell surface ...ead to tumor cell growth and,proliferation, and in...
...ss.--(BUSINESS WIRE)--Jun 5, 2007 - Elixir,Pharmac...ta,confirming ghrelin antagonism as a potential me...ight and managing blood glucose. The,data were pre...crine Society,s 89th Annual Meeting, being held in...ment of drugs to treat and,prevent metabolic disea...
Other Medicine Technology:Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4
...ghput immunoassay system built around the many pos...important addition of Logic Driven Incubation (LDI...for optimal performance with the fastest possible ...ys such as the cardiac biomarkers and HCG to be ru...
For The Detection Of Serum C-Peptide Levels.,Clinical Uses Of C-Peptide Measurement:, Evaluating patients with fasting hypoglycemia , Assisting in the classification of diabetes mellitus , D
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
Medicine Products: